ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 80 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,827.50
Market cap: ₹1,06,141 Cr
Revenue (annual): ₹33,653 Cr
Net profit (annual): ₹3,505 Cr
P/E (TTM): 25.2×Sector 43.8×
Promoter holding: 51.88%+0.00% QoQ
FII holding: 17.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 2 Results Update 1 Other Announcement 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Earnings Call 1 Dividend 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Nov 2026 19:53 IST NSE

Financial Results

Aurobindo Pharma Q2 FY27 Results: Net Profit ₹1,124 Cr, Up 32.5% YoY

Aurobindo Pharma Ltd reported revenue from operations of ₹10,263 Cr (+23.9% YoY) and net profit of ₹1,124 Cr (+32.5% YoY) for Q2 FY27.

Key figure: Net profit ₹1,124 Cr · +32.5% YoY

Open full results → Read the filing ↗

Aurobindo Pharma Ltd by type